suberoyl bis-hydroxamic acid and pyrazines

suberoyl bis-hydroxamic acid has been researched along with pyrazines in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Dai, Y; Grant, S; Jones, R; Kmieciak, M; Leng, Y; Lin, H; Orlowski, RZ; Pei, XY; Zhang, Y; Zhou, L	1

Other Studies

1 other study(ies) available for suberoyl bis-hydroxamic acid and pyrazines

Article	Year
A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. Blood, 2014, Oct-23, Volume: 124, Issue:17 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Bcl-2-Like Protein 11; Boronic Acids; Bortezomib; Cell Line, Tumor; Cells, Cultured; Drug Resistance, Neoplasm; Fluorescent Antibody Technique; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoblotting; Membrane Proteins; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Multiple Myeloma; Proto-Oncogene Proteins; Pyrazines; RNA Interference; Tumor Burden; Xenograft Model Antitumor Assays	2014

Article

Year

A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis.

Blood, 2014, Oct-23, Volume: 124, Issue:17

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Bcl-2-Like Protein 11; Boronic Acids; Bortezomib; Cell Line, Tumor; Cells, Cultured; Drug Resistance, Neoplasm; Fluorescent Antibody Technique; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunoblotting; Membrane Proteins; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Multiple Myeloma; Proto-Oncogene Proteins; Pyrazines; RNA Interference; Tumor Burden; Xenograft Model Antitumor Assays

2014